CCc1cc2c(=O)n(CCCOC)c(SCC(=O)Nc3oc(C)c4c(C)nnc(O)c34)nc2s1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?